Sammanish, WA, United States of America

Peter Carbonaro


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Peter Carbonaro: Innovator in Pharmaceutical Manufacturing

Introduction

Peter Carbonaro, an inventive mind based in Sammanish, Washington, has made significant contributions to the field of pharmaceutical manufacturing. As an inventor, his work focuses on enhancing the production processes related to critical medical compounds.

Latest Patents

Carbonaro holds a patent for a "Process for manufacturing bulk solutions and a lyophilized pure α-aztreonam lysinate." This innovation details a method for manufacturing large-scale production of inhalable aztreonam, a crucial antibiotic used in treating respiratory infections. The patent further describes a dry powder or lyophilized composition of pure α-aztreonam lysinate specifically designed for inhalation, providing valuable advancements in drug delivery systems.

Career Highlights

Peter currently works with Corus Pharma, Inc., where he utilizes his expertise to drive forward revolutionary developments in the pharmaceutical industry. His commitment to advancing medical solutions through innovative manufacturing processes is evident in his pioneering patent work.

Collaborations

Throughout his career, Carbonaro has collaborated with prominent coworkers such as Alan Bruce Montgomery and Iain W. Duncan. Together, they have worked towards improving pharmaceutical formulations and manufacturing techniques, underscoring the importance of teamwork in driving innovation.

Conclusion

Peter Carbonaro's contributions to pharmaceutical engineering highlight the impact of innovation on public health. Through his dedication and inventive spirit, he continues to play a vital role in the development of effective therapies for patients in need. His patent reflects a significant advancement within the industry, showcasing the potential of targeted pharmaceutical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…